Real-World Results on Ibrutinib in Relapsed/Refractory CLL: A 21-Month Follow-up of 95 Swedish Patients Treated in a Compassionate Use Program

被引：0
|
作者：
Winqvist, Maria
Andersson, Per-Ola
Asklid, Anna
Karlsson, Karin
Karlsson, Claes
Lauri, Birgitta
Lundin, Jeanette
Mattsson, Mattias
Norin, Stefan
Sandstedt, Anna Bergendahl
Hansson, Lotta
Osterborg, Anders
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5353
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Real-World Results on Ibrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL): Data from 97 Swedish Patients Treated in a Compassionate Use Program
    Hansson, Lotta
    Winqvist, Maria
    Asklid, Anna
    Andersson, P-O
    Karlsson, Karin
    Karlsson, Claes
    Lauri, Birgitta
    Lundin, Jeanette
    Mattsson, Mattias
    Norin, Stefan
    Sandstedt, Anna
    Osterborg, Anders
    BLOOD, 2015, 126 (23)
  • [2] Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort
    Winqvist, Maria
    Andersson, Per-Ola
    Asklid, Anna
    Karlsson, Karin
    Karlsson, Claes
    Lauri, Birgitta
    Lundin, Jeanette
    Mattsson, Mattias
    Norin, Stefan
    Sandstedt, Anna
    Rosenquist, Richard
    Spath, Florentin
    Hansson, Lotta
    Osterborg, Anders
    HAEMATOLOGICA, 2019, 104 (05) : E208 - E210
  • [3] Real-world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: data from 95 consecutive patients treated in a compassionate use program. A study from the Swedish Chronic Lymphocytic Leukemia Group
    Winqvist, Maria
    Asklid, Anna
    Andersson, P. O.
    Karlsson, Karin
    Karlsson, Claes
    Lauri, Birgitta
    Lundin, Jeanette
    Mattsson, Mattias
    Norin, Stefan
    Sandstedt, Anna
    Hansson, Lotta
    Osterborg, Anders
    HAEMATOLOGICA, 2016, 101 (12) : 1573 - 1580
  • [4] Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients
    Ysebaert, Loic
    Aurran-Schleinitz, Therese
    Dartigeas, Caroline
    Dilhuydy, Marie-Sarah
    Feugier, Pierre
    Michallet, Anne-Sophie
    Tournilhac, Olivier
    Dupuis, Jehan
    Sinet, Pierre
    Albrecht, Claire
    Cymbalista, Florence
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E166 - E168
  • [5] Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in Denmark
    Trab, Trine
    Chanchiri, Iman
    Al-Mashhadi, Ahmed
    Berggreen, Emma
    Rasch, Stine
    Johansen, Mette
    Husby, Simon
    Clausen, Michael Roost
    Larsen, Thomas Stauffer
    Desseau-Arp, Andriette C.
    Christensen, Jacob Haaber
    Pedersen, Robert Schou
    Frederiksen, Mikael
    Brown, Peter de Nully
    El-Galaly, Tarec Christoffer
    Gronbaek, Kirsten
    BLOOD, 2024, 144 : 6325 - 6326
  • [6] The Use of Ibrutinib in Italian CLL Patients Treated in a Real-World Setting (EVIDENCE): A Preliminary Report
    Molica, Stefano
    Scalzulli, Potito Rosario
    Scarfo, Lydia
    Guarini, Attilio
    Murru, Roberta
    Sportoletti, Paolo
    Frigeri, Ferdinando
    Albano, Francesco
    Di Renzo, Nicola
    Sanna, Alessandro
    Innocenti, Idanna
    Massaia, Massimo
    Coscia, Marta
    Pennese, Elsa
    Patti, Caterina
    Reda, Gianluigi
    Tafuri, Agostino
    Grugnetti, Anna
    Magarotto, Valeria
    Mauro, Francesca Romana
    BLOOD, 2021, 138
  • [7] Epcoritamab for Relapsed/Refractory B Cell Lymphoma- the Israeli Real-World Experience of a Compassionate Use Program
    Aumann, Shlomzion
    Avigdor, Abraham
    Marcus, Ronit
    Horowitz, Netanel A.
    Gurion, Ronit
    Tadmor, Tamar
    Vitkon, Roy
    Basood, May Meira
    Abadi, Uri
    Kedmi, Meirav
    BLOOD, 2024, 144 : 5124 - 5125
  • [8] The 5-year follow-up of a real-world observational study of patients in the United Kingdom and Ireland receiving ibrutinib for relapsed/refractory mantle cell lymphoma
    Tucker, David
    Morley, Nick
    MacLean, Peter
    Vandenberghe, Elisabeth
    Parisi, Lori
    Rule, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (06) : 1035 - 1038
  • [9] Prognostic Value of TTM with TTM Distribution and Ball Score in Relapsed/Refractory Ibrutinib Treated B-CLL - in the Real-World Setting
    Jaksic, Ozren
    Ivic, Marija
    Kusec, Rajko
    Mitrovic, Zdravko
    Pirsic, Mario
    Jaksic, Branimir
    Cicic, David
    Pejsa, Vlatko
    BLOOD, 2020, 136
  • [10] REAL-WORLD TREATMENT OUTCOMES AMONG RELAPSED/REFRACTORY PATIENTS WITH MANTLE CELL LYMPHOMA TREATED WITH IBRUTINIB OR ACALABRUTINIB
    Crawford, S.
    Lafeuille, M. H.
    Emond, B.
    Harb, D.
    Voladarsky, R.
    Chen, N.
    Karve, S.
    VALUE IN HEALTH, 2023, 26 (06) : S403 - S403
12345